1.Fan YC, Liang JJ, Chen JM, Lin JW, Chen YY, Su KH, Lin CC, Tu WC, Chiou MT, Ou SC, Chang GJ, Lin YL, Chiou SS. 2019. Enhancement of genotype I Japanese encephalitis virus infectivity in amplifying Hosts associated with NS2B/NS3 mutations. PLoS Pathogens. 5(8):e1007992. (IF=6.463, Rank: 3/36)
2.Fan YC, Chen JM, Lin JW, Chen YY, Wu GH, Su KH, Chiou MT, Wu SR, Yin JH, Liao JW, Chang GJJ, Chiou SS. 2018. Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine. Scientific Reports. 8:7481. (IF=4.011, Rank: 15/69)
3.Fan YC, Lin JW, Liao SY, Chen JM, Chen YY, Chiu HC, Shih CC, Chen CM, Chang RY, King CC, Chen WJ, Ko YT, Chang CC, and Chiou SS*. 2017. Virulence of Genotypes I and III Japanese Encephalitis Virus in Humans. Emerging Infectious Diseases. 23(11):1883-1886. (IF=7.422, Rank: 4/88)
4.Chen JM, Fan YC, Lin JW, Chen YY, Hsu WL, Chiou SS. 2017. Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN. Int J Mol Sci. 18(9). pii: E1957. (IF=4.183, Rank: 78/298)
5.Fan YC, Chiu HC, Chen LK, Chang GJJ, and Chiou SS*. 2015. Formalin inactivation of Japanese encephalitis virus vaccine s the antigenicity and immunogenicity of a neutralization epitope in envelope protein domain III. PLoS Neglected Tropical Diseases. 9(10): e0004167. (IF=4.487, Rank: 1/21)
6.Chen YY, J.W. Lin, Y.C. Fan, and Chiou SS* 2014. Detection and Differentiation of Genotype I and III Japanese Encephalitis Virus in Mosquitoes by Multiplex Reverse Transcriptase-Polymerase Chain Reaction. Transboundary and Emerging Diseases. 61(1): 37-43. (IF=3.554, Rank: 2/141)
7.Fan YC, Chen JM, Chen YY, Lin JW, Chiou SS.* 2013. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine. Vet Microbiol. 163(3-4): 248-56. (IF=2.791, Rank: 7/141)
8.Chen YY, Lin JW, Fan YC, Tu WC, Chang GJ, Chiou SS.* 2013. First detection of the Africa/Caribbean/Latin American subtype of Culex flavivirus in Asian country, Taiwan. Comp Immunol Microbiol Infect Dis. 36(4): 387-96. (IF=2.107, Rank: 12/132)
9.Fan YC, J.M. Chen, H.C. Chiu, Y.Y. Chen, J.W. Lin, C.C. Shih, C.M. Chen, C.C. Chang, G.J.J. Chang, and Chiou SS*. Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine. PLoS Neglected Tropical Diseases. 2012; 6(9):e1834-1843. (IF=4.569, Rank: 1/22)
10.Chiou SS, Fan YC, Crill WD, Chang RY, and Chang GJ. (2012). Mutation Analysis of the Cross Reactive Epitopes of Japanese Encephalitis Virus Envelope Glycoprotein. Journal of General Virology 93:1185-1192. (IF=3.127, Rank: 11/34)
11.Chen YY, Fan YC, Tu WC, Chang RY, Shih CC, Lu IH, Chien MS, Lee WC, Chen TH, Chang GJ, Chiou SS.* (2011). Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010. Emerging Infectious Diseases. 17(12):2354-6. (IF=7.185, Rank: 5/89)
12.Chiou SS, Crill WD, Chen LK, and Chang GJJ. 2008. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol. 2008 May;15(5):825-35.
13.Chien YJ, Chen WJ, Hsu WL, Chiou SS*. 2008. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology. 15;379(1):143-51.
14.Chiou SS, and Chen WJ. (2007). Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus. Vaccine 26:15-23.
15.Chiou SS, Tsai KH, Huang CG, Liao YK, and Chen WJ. (2007). High antibody prence in an unconventional eco is related to circulation of a low-virulent strain of Japanese encephalitis virus. Vaccine 25:1437-1443.
16.Chiou SS, Liu H, Chuang CK, and Chen WJ. (2005). Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of viral envelope protein with highly sulfated glycosaminoglycans on the cell surface. Journal of Medical Virology 76:583–592.
17.Liu H, Chiou SS, and Chen WJ. (2004). Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants with heparan sulfate on the cell surface. Journal of Medical Virology 72:618–624.
18.Chuang CK, Chiou SS, Liang LC, and Chen WJ. (2003). Detection of Japanese encephalitis virus inside peripheral blood mononuclear cells of mouse using in situ RT-PCR. American Journal of Tropical Medicine and Hygiene 69(6): 648-651.
19.Chen WJ, Wu HR, and Chiou SS. (2003). E/NS1 modifications of dengue 2 virus after serial passages in mammalian and/or mosquito cells. Intervirology 46: 289-295.
20.Chiou SS, and Chen WJ. (2001). Mutation in the NS3 gene and 3’-NCR of Japanese encephalitis virus isolated from an unconventional eco and implications for natural attenuation of the virus. Virology 289: 129-136.